BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 8, 2000
View Archived Issues
BioCryst strengthens drug candidate pipeline
Read More
Proteasome inhibitor PS-519 protective in cerebral ischemia model
Read More
GABA-B antagonist CGP-36742 promnestic in epilepsy model
Read More
NIH to conduct trials of potential new transplant therapy for diabetes
Read More
Incyte and Elitra establish antimicrobial genomics alliance
Read More
FDA approves Glucovance for treatment of type 2 diabetes
Read More
CRF1 receptor antagonist displays safety and efficacy in clinical trial
Read More
Research advances the use of transgenic plants to deliver vaccines
Read More
CGS-21680 promising agent for myocardial perfusion imaging
Read More
PR-000350 shows promise in improving efficacy of radiation therapy
Read More
Allovectin-7 phase I/II data released
Read More
Aventis seeks approval of Dynepo in U.S. and Europe
Read More
Icos and Array BioPharma expand collaboration
Read More
AMBI licenses nisin and lysostaphin to Biosynexus
Read More
Ginkgo biloba extract shows promise as treatment for dementia
Read More
Novel arylpiperazines assessed as uroselective agents for BPH
Read More
Once-daily postoperative dosing approved for Fragmin
Read More
Forest licenses dexloxiglumide from Rotta for treatment of IBS
Read More
New serine protease inhibitors useful for thromboembolic disorders
Read More
New serine protease inhibitors useful for treating cancer
Read More
New HIV integrase inhibitors under study at Merck & Co.
Read More
DNA topoisomerase II inhibitors under study at Lafon
Read More
New alpha4-integrin antagonists useful for asthma, etc.
Read More
New IL-5 inhibitors under development at Janssen
Read More
New antimicrobial agents under development at SmithKline Beecham
Read More